Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

PublicNASDAQ:ZGNX
Date12/2010
Raised
Post IPO Valuation

General Information

Offices

HQ
12671 High Bluff Dr
San Diego, CA, 92130
USA

People

Co-founder, CEO
President, COO
Board of Directors
Board Member
Board of Directors
Boards of Directors
Director
Director
Show All People

Funding

Tags

Zogenix

At Zogenix, our core strategy is to develop and commercialize differentiated central nervous system (CNS) and pain therapeutics that can address significant unmet medical needs or overcome limitations of existing products.

We are a specialty pharmaceutical company with two proprietary product candidates in late-stage development for the treatment of central nervous system disorders and pain. Our lead product candidate, sumatriptan DoseProâ„¢, enables needle-free subcutaneous delivery of sumatriptan for the treatment of acute migraine. Our second product candidate, ZX002, is a novel controlled release formulation of hydrocodone for the treatment of chronic pain.

Recent Milestones

  • Check
    Zogenix — Turnaround Tuesday: Troubled Zogenix To Raise $56M (11/12/13)
    Posted 11/12/13 at 9:00pm via themiddlemarket.com
  • Check
    Zogenix — ZOGENIX GETS PENTAGON CONTRACT WORTH UP TO $20.7M (9/30/13)
    Posted 10/1/13 at 8:48pm via tm-partners.com
  • Stock
    Went public with stock symbol NASDAQ:ZGNX. (12/3/10)
    Posted 10/1/13 at 8:46pm
  • Check
    Zogenix — Zogenix Posts Modest Loss In Public Debut (11/24/10)
    Posted 11/29/10 at 11:08pm via dowjones.com
  • Check
    Zogenix — Pharma Co Zogenix Files To Sell Up To $90M Of Stock In IPO (9/3/10)
    Posted 9/7/10 at 8:42pm via wsj.com
  • Dollar
    Zogenix received $15M in Venture Round funding. (7/13/10)
    Posted 10/31/10 at 7:28pm via zogenix.com
  • Dollar
    Zogenix received $35M in Series B funding. (12/15/09)
    Posted 12/7/09 at 5:11pm via sec.gov
  • Dollar
    Zogenix received $36M in Series B funding. (10/5/09)
    Posted 9/24/09 at 2:04am via sec.gov
  • Dollar
    Zogenix received $3.1M in Debt funding. (5/29/09)
    Posted 2/18/14 at 8:56pm via sec.gov
  • Dollar
    Zogenix received $18M in Venture Round funding. (1/9/08)
    Posted 12/20/09 at 8:04pm via zogenix.com
  • Dollar
    Zogenix received $60M in Series A funding. (8/28/06)
    Posted 4/19/10 at 9:15pm via zogenix.com
  • Check
    Zogenix added Jonathan M. Rigby as Co-Founder. (1/1/06)
    Posted 3/13/14 at 2:17am
  • Check
    Zogenix added Roger Hawley as Co-founder, CEO.
    Posted 12/15/09 at 1:30pm
  • Check
    Zogenix added Alex Zisson as Director.
    Posted 12/15/09 at 1:30pm
  • Check
    Zogenix added Stephen Farr as President, COO.
    Posted 12/15/09 at 1:30pm
  • Check
    Zogenix added Cam Garner as Chairman.
    Posted 12/15/09 at 1:30pm

Videos

Screenshots

Zogenix screenshot
Above: Zogenix Screenshot -- #1
Uploaded: 9/24/09

Stock Price

Sources

  1. Zogenix, Inc. Raises $60 Million In Series A Venture Financing; Names Board of Directors (zogenix.com) [edit]
  2. Zogenix Raises $18 Million in Preferred Stock Financing (zogenix.com) [edit]
  3. SEC (sec.gov) [edit]
  4. SEC D (sec.gov) [edit]
  5. SEC D/A (sec.gov) [edit]
  6. Zogenix Secures $35 Million Debt Facility And Raises $15 Million Investment Capital (zogenix.com) [edit]
  7. Pharma Co Zogenix Files To Sell Up To $90M Of Stock In IPO (online.wsj.com) [edit]
    Zogenix Posts Modest Loss In Public Debut (fis.dowjones.com) [edit]
    ZOGENIX GETS PENTAGON CONTRACT WORTH UP TO $20.7M (tm-partners.com) [edit]
    Turnaround Tuesday: Troubled Zogenix To Raise $56M (themiddlemarket.com) [edit]
Edit This Page
Last Edited 3/13/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy